Df Dent & CO Inc Amgen Inc Transaction History

Df Dent & CO Inc

$7.12 Billion
Q2 2024

A detailed history of Df Dent & CO Inc transactions in Amgen Inc stock. As of the latest transaction made, Df Dent & CO Inc holds 2,600 shares of AMGN stock, worth $821,600. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,600

Previous 2,617 0.65%

Holding current value

$821,600

Previous $744,000 9.14%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $4,466 - $5,428	-17 Reduced 0.65%	2,600 $812,000
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $107,548 - $129,824	400 Added 18.04%	2,617 $744,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $3,815 - $4,303	17 Added 0.77%	2,217 $500,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $99,767 - $110,369	-455 Reduced 17.14%	2,200 $532,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $22,871 - $26,174	-115 Reduced 4.15%	2,655 $597,000
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $245,432 - $286,011	-1,106 Reduced 28.53%	2,770 $689,000
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $1,877 - $2,087	-8 Reduced 0.21%	3,876 $985,000
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $188,315 - $231,088	-952 Reduced 19.69%	3,884 $916,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $30,980 - $41,089	-170 Reduced 3.4%	4,836 $980,000
Q2 2019 Aug 15, 2019	SELL	$166.7 - $195.41 $25,005 - $29,311	-150 Reduced 2.91%	5,006 $923,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $63,304 - $71,358	350 Added 7.28%	5,156 $980,000
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $814,280 - $951,588	4,806 New	4,806 $819,000
Q4 2017 Feb 15, 2018	SELL	$168.79 - $188.59 $237,318 - $265,157	-1,406 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $235,209 - $268,546	1,406	1,406 $262,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Df Dent & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Df Dent & CO Inc with notifications on news.

Account